Despite the importance of chemotherapy-associated adverse events in oncology practice
and the broad range of interventions available to mitigate them, limited systematic efforts …

Aims To examine the prevalence and associated factors of chemotherapy‐related cognitive
impairment (CRCI) in older breast cancer survivors (BCS). Design Systematic review. Data …

PURPOSE To examine longitudinal relationships between levels of C-reactive protein
(CRP) and cognition in older breast cancer survivors and noncancer controls. METHODS …

Cognitive assessment is a cornerstone of geriatric care. Cognitive impairment has the
potential to significantly impact multiple phases of a person's cancer care experience …

Cognitive function can be affected by cancer and/or its treatment, and older patients are at a
particular risk. In a prospective observational study including patients≥ 65 years referred for …

PURPOSE Cognitive decline is frequently observed after chemotherapy. As chemotherapy
is associated with changes in brain white matter microstructure, we investigated whether …

Background Immune activation/inflammation markers (immune markers) were tested to
explain differences in neurocognition among older breast cancer survivors versus …

Objectives Physical and cognitive function are two of the most important patient-reported
outcomes. In oncology patients receiving chemotherapy (N= 1331), purposes were to …

Cardiovascular disease (CVD) and cancer are leading causes of death globally, particularly
among the rapidly growing population of older adults (OAs). CVD is a leading cause of …

Purpose We evaluated whether plasma Alzheimer's Disease (AD)-related biomarkers were
associated with cancer-related cognitive decline (CRCD) among older breast cancer …